Atlas Trials

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults

Clinical trial NCT02182765 · TERMINATED

Trial details

NCT number
NCT02182765
Sponsor
Boehringer Ingelheim
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Start date
1999-04-01
Primary completion
2001-07-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.